| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 17 | 2026 | 526 | 3.580 |
Why?
|
| Intellectual Disability | 10 | 2025 | 1048 | 1.380 |
Why?
|
| Phenotype | 21 | 2026 | 4304 | 1.150 |
Why?
|
| Nuclear Proteins | 4 | 2025 | 1204 | 1.110 |
Why?
|
| Listeriosis | 3 | 2017 | 20 | 1.080 |
Why?
|
| Listeria monocytogenes | 3 | 2017 | 30 | 0.980 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2025 | 14 | 0.920 |
Why?
|
| Microcephaly | 3 | 2025 | 343 | 0.910 |
Why?
|
| Seizures, Febrile | 1 | 2025 | 31 | 0.900 |
Why?
|
| Microglia | 2 | 2025 | 128 | 0.880 |
Why?
|
| Apyrase | 1 | 2022 | 20 | 0.750 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 29 | 0.740 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 145 | 0.730 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2025 | 248 | 0.730 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2023 | 61 | 0.720 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.720 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2023 | 219 | 0.710 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 9 | 0.700 |
Why?
|
| Peroxisomal Disorders | 1 | 2021 | 18 | 0.700 |
Why?
|
| Achondroplasia | 1 | 2021 | 24 | 0.680 |
Why?
|
| Migraine with Aura | 1 | 2021 | 16 | 0.680 |
Why?
|
| Hemiplegia | 1 | 2021 | 42 | 0.680 |
Why?
|
| White Matter | 2 | 2022 | 205 | 0.660 |
Why?
|
| Membrane Proteins | 3 | 2025 | 1569 | 0.660 |
Why?
|
| Pedigree | 9 | 2025 | 1656 | 0.650 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 80 | 0.650 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 270 | 0.580 |
Why?
|
| Genetic Association Studies | 2 | 2025 | 808 | 0.580 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 398 | 0.570 |
Why?
|
| Interferon-beta | 2 | 2017 | 54 | 0.570 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2025 | 3262 | 0.560 |
Why?
|
| Mutation | 8 | 2024 | 5941 | 0.550 |
Why?
|
| Epilepsy | 2 | 2022 | 844 | 0.530 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 533 | 0.530 |
Why?
|
| Mutation, Missense | 7 | 2026 | 891 | 0.510 |
Why?
|
| Complement System Proteins | 1 | 2016 | 57 | 0.500 |
Why?
|
| Homozygote | 4 | 2024 | 540 | 0.460 |
Why?
|
| Developmental Disabilities | 4 | 2025 | 718 | 0.460 |
Why?
|
| Humans | 50 | 2026 | 126753 | 0.430 |
Why?
|
| Spleen | 1 | 2014 | 253 | 0.410 |
Why?
|
| Interferon-alpha | 1 | 2014 | 237 | 0.390 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 156 | 0.390 |
Why?
|
| Genomics | 4 | 2024 | 1546 | 0.370 |
Why?
|
| Seizures | 4 | 2025 | 847 | 0.350 |
Why?
|
| Male | 25 | 2026 | 62543 | 0.310 |
Why?
|
| Nervous System Malformations | 2 | 2022 | 119 | 0.310 |
Why?
|
| Epithelial Cells | 2 | 2011 | 870 | 0.310 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2011 | 208 | 0.290 |
Why?
|
| Animals | 20 | 2025 | 33051 | 0.290 |
Why?
|
| Zebrafish | 3 | 2025 | 402 | 0.280 |
Why?
|
| RNA Splicing | 3 | 2026 | 230 | 0.270 |
Why?
|
| Child, Preschool | 13 | 2026 | 14347 | 0.260 |
Why?
|
| Lung Diseases | 1 | 2011 | 395 | 0.260 |
Why?
|
| Loss of Function Mutation | 2 | 2024 | 151 | 0.250 |
Why?
|
| Haploinsufficiency | 2 | 2025 | 265 | 0.250 |
Why?
|
| Child | 15 | 2026 | 25101 | 0.240 |
Why?
|
| Congenital Disorders of Glycosylation | 2 | 2023 | 39 | 0.240 |
Why?
|
| Complement C5a | 2 | 2017 | 19 | 0.240 |
Why?
|
| Guanylate Kinases | 1 | 2025 | 18 | 0.240 |
Why?
|
| RNA Splicing Factors | 1 | 2026 | 52 | 0.240 |
Why?
|
| Drosophila Proteins | 4 | 2025 | 757 | 0.240 |
Why?
|
| Adolescent | 13 | 2026 | 20002 | 0.240 |
Why?
|
| Genetic Variation | 3 | 2024 | 1508 | 0.230 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2025 | 12 | 0.230 |
Why?
|
| tRNA Methyltransferases | 1 | 2025 | 5 | 0.230 |
Why?
|
| Mammals | 2 | 2023 | 247 | 0.230 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2023 | 160 | 0.230 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 578 | 0.230 |
Why?
|
| Spliceosomes | 1 | 2025 | 47 | 0.230 |
Why?
|
| Alternative Splicing | 2 | 2026 | 296 | 0.230 |
Why?
|
| Arthrogryposis | 1 | 2025 | 36 | 0.220 |
Why?
|
| Infant | 11 | 2026 | 12771 | 0.220 |
Why?
|
| RNA, Transfer | 1 | 2025 | 68 | 0.220 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2021 | 26 | 0.220 |
Why?
|
| Zellweger Syndrome | 1 | 2024 | 16 | 0.220 |
Why?
|
| Polyneuropathies | 1 | 2024 | 30 | 0.220 |
Why?
|
| Cerebellar Diseases | 1 | 2025 | 77 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 58 | 0.220 |
Why?
|
| Drosophila melanogaster | 3 | 2025 | 808 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2024 | 119 | 0.210 |
Why?
|
| Vesicular Transport Proteins | 2 | 2024 | 137 | 0.210 |
Why?
|
| Immunity, Innate | 2 | 2017 | 394 | 0.210 |
Why?
|
| Alleles | 6 | 2025 | 1609 | 0.210 |
Why?
|
| Phosphoproteins | 1 | 2026 | 420 | 0.210 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 14 | 0.200 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 48 | 0.200 |
Why?
|
| Mice | 10 | 2023 | 17596 | 0.200 |
Why?
|
| Paraparesis, Spastic | 1 | 2023 | 4 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2024 | 234 | 0.200 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2023 | 75 | 0.200 |
Why?
|
| Microphthalmos | 1 | 2023 | 53 | 0.200 |
Why?
|
| Cerebellar Ataxia | 1 | 2023 | 69 | 0.190 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.190 |
Why?
|
| Translocation, Genetic | 1 | 2024 | 348 | 0.190 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 10 | 0.190 |
Why?
|
| Dysarthria | 1 | 2022 | 24 | 0.190 |
Why?
|
| Osteoporosis | 1 | 2023 | 132 | 0.190 |
Why?
|
| Racemases and Epimerases | 1 | 2022 | 12 | 0.190 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2022 | 12 | 0.190 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 66 | 0.190 |
Why?
|
| NADP | 1 | 2022 | 52 | 0.190 |
Why?
|
| NAD | 1 | 2022 | 50 | 0.180 |
Why?
|
| DNA Helicases | 1 | 2023 | 229 | 0.180 |
Why?
|
| Paraplegia | 1 | 2022 | 88 | 0.180 |
Why?
|
| Chromosome Aberrations | 1 | 2024 | 570 | 0.180 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 99 | 0.180 |
Why?
|
| Apnea | 1 | 2021 | 27 | 0.170 |
Why?
|
| Facies | 1 | 2021 | 156 | 0.170 |
Why?
|
| Female | 19 | 2026 | 68330 | 0.170 |
Why?
|
| Atrioventricular Block | 1 | 2021 | 45 | 0.170 |
Why?
|
| Young Adult | 4 | 2025 | 9665 | 0.170 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 132 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2023 | 221 | 0.160 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2020 | 3 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 48 | 0.160 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 35 | 0.160 |
Why?
|
| Cell Line | 2 | 2023 | 2560 | 0.160 |
Why?
|
| Proteomics | 1 | 2024 | 562 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 49 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 60 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 249 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2022 | 207 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 134 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 652 | 0.150 |
Why?
|
| Software | 1 | 2024 | 711 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 225 | 0.150 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 167 | 0.150 |
Why?
|
| Mitochondria | 1 | 2024 | 730 | 0.140 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 1004 | 0.140 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2023 | 422 | 0.140 |
Why?
|
| Calcinosis | 1 | 2020 | 184 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 1707 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2021 | 359 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2025 | 701 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2024 | 1056 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2020 | 283 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2025 | 2337 | 0.130 |
Why?
|
| Complement C3a | 1 | 2017 | 19 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 272 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1098 | 0.120 |
Why?
|
| Complement Activation | 1 | 2016 | 49 | 0.120 |
Why?
|
| Syndrome | 3 | 2023 | 1137 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 393 | 0.120 |
Why?
|
| Interferon Type I | 1 | 2016 | 107 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2024 | 1105 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2021 | 967 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 99 | 0.120 |
Why?
|
| Echocardiography | 1 | 2021 | 1114 | 0.120 |
Why?
|
| Drosophila | 3 | 2025 | 767 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 972 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1877 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 968 | 0.110 |
Why?
|
| Complement C5b | 1 | 2014 | 1 | 0.110 |
Why?
|
| Anaphylatoxins | 1 | 2014 | 3 | 0.110 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2014 | 14 | 0.110 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 21 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3709 | 0.110 |
Why?
|
| Receptors, Interferon | 1 | 2014 | 20 | 0.110 |
Why?
|
| Bacterial Load | 1 | 2014 | 33 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 125 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 251 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 1351 | 0.100 |
Why?
|
| Antibodies | 1 | 2014 | 351 | 0.100 |
Why?
|
| Muscle Hypotonia | 2 | 2025 | 188 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2014 | 354 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2332 | 0.100 |
Why?
|
| Adult | 5 | 2025 | 30410 | 0.090 |
Why?
|
| Rare Diseases | 2 | 2024 | 201 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2014 | 1495 | 0.090 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 35 | 0.080 |
Why?
|
| Gene Expression | 1 | 2014 | 1482 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 269 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2026 | 4954 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 64 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2023 | 767 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 137 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2011 | 166 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3695 | 0.070 |
Why?
|
| Apoptosis | 1 | 2014 | 1811 | 0.070 |
Why?
|
| Liver | 1 | 2014 | 1765 | 0.060 |
Why?
|
| Interleukin-9 | 1 | 2006 | 7 | 0.060 |
Why?
|
| Disease Progression | 2 | 2023 | 2109 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 220 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2025 | 67 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4472 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3390 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2006 | 152 | 0.050 |
Why?
|
| R-SNARE Proteins | 1 | 2024 | 22 | 0.050 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 8 | 0.050 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 16 | 0.050 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 124 | 0.050 |
Why?
|
| Carcinoma | 1 | 2006 | 279 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 98 | 0.050 |
Why?
|
| Cations | 1 | 2023 | 37 | 0.050 |
Why?
|
| Glycosylation | 1 | 2023 | 111 | 0.050 |
Why?
|
| Ion Channels | 1 | 2025 | 201 | 0.050 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 55 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 133 | 0.050 |
Why?
|
| Retinoids | 1 | 2023 | 29 | 0.050 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2023 | 97 | 0.050 |
Why?
|
| RNA, Small Nuclear | 1 | 2023 | 41 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2023 | 55 | 0.050 |
Why?
|
| Alopecia | 1 | 2023 | 40 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2022 | 9 | 0.050 |
Why?
|
| Lung | 1 | 2011 | 1516 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 275 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2023 | 237 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 176 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 243 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 12 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2022 | 35 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 130 | 0.050 |
Why?
|
| Egypt | 1 | 2021 | 27 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2023 | 404 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2022 | 90 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2022 | 52 | 0.050 |
Why?
|
| Turkey | 1 | 2021 | 64 | 0.040 |
Why?
|
| Calpain | 1 | 2021 | 41 | 0.040 |
Why?
|
| Actins | 1 | 2023 | 311 | 0.040 |
Why?
|
| Atrophy | 1 | 2022 | 237 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2023 | 684 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 400 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 95 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2022 | 172 | 0.040 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 5 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2020 | 78 | 0.040 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 23 | 0.040 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 52 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 576 | 0.040 |
Why?
|
| Biological Factors | 1 | 2020 | 26 | 0.040 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 17 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 136 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 350 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 27 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 224 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 46 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2024 | 381 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 72 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 149 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 819 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 422 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 100 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 167 | 0.040 |
Why?
|
| Axons | 1 | 2022 | 373 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1064 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 358 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 515 | 0.040 |
Why?
|
| Genotype | 1 | 2025 | 2595 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 398 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 1931 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 160 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 272 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 250 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8347 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3314 | 0.030 |
Why?
|
| Genome, Human | 1 | 2024 | 1279 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 330 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 516 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 406 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1236 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2537 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1137 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2017 | 222 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3662 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 541 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 640 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 899 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 783 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 1014 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2591 | 0.030 |
Why?
|
| Brain | 1 | 2025 | 3038 | 0.030 |
Why?
|
| Risk Factors | 1 | 2025 | 10555 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 330 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 230 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 946 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 4504 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 20344 | 0.020 |
Why?
|
| Janus Kinase 3 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4429 | 0.020 |
Why?
|
| Oxygen | 1 | 2010 | 541 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1204 | 0.020 |
Why?
|
| G1 Phase | 1 | 2006 | 65 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 148 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 841 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1842 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2397 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17005 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 27697 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 2310 | 0.010 |
Why?
|